Physician profile
Jennifer Wright
NPI 1427729441
$1,006.53
in general payments reported to CMS, 2019-2025
12 companies · $661 in 2025
The $661 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $346 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $240.40 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $227.97 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $125.91 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.87 | 2024-2025 | Jardiance |
| Aimmune Therapeutics, INC. | $55.92 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $53.94 | 2024 | Rexulti |
| Amgen INC. | $53.09 | 2025 | Repatha, Otezla |
| Phathom Pharmaceuticals, INC. | $43.53 | 2025 | Voquezna |
| Ardelyx, INC. | $34.11 | 2025 | Ibsrela |
| Lilly USA, LLC | $20.93 | 2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.29 | 2024 | Xifaxan |
| Vivus LLC | $14.57 | 2025 | Pancreaze |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.